Wanbury reports 88% drop in Q3 FY25 PAT
Revenue from operations also dropped 8.3 per cent at Rs. 133.5 crore in Q3 FY25
Revenue from operations also dropped 8.3 per cent at Rs. 133.5 crore in Q3 FY25
Glenmark’s consolidated revenue was at Rs. 3,387.6 crore as against Rs. 2,506.7 crore recording an increase of 35.1% YoY
Revenue up 11% to Rs 5,768 crore as compared to Rs 5,197 crore
Wockhardt also saw its revenue from operations increased 3% to Rs. 721 crore during Q3 FY25
Branded formulation business continues to perform well across domestic and export markets
The stable raw materials prices, focused cost improvement initiatives and intensified customer acquisitions helped the company to improve its margin profile
Profit after Taxes registered strong growth of 22% to Rs. 162 crores versus Rs. 134 crores in Q3 FY24
Our Q3 FY25 revenue was at Rs. 1,384.1 crore with an EBITDA of Rs. 360 crore resulting in a 26% EBITDA margin
EBITDA rose to Rs. 14.8 crore, marking a 16.5% y-o-y increase, while net profit surged to Rs. 6.4 crore
EBITDA grew by 11% on a YoY basis to Rs. 296 crore due to improved performance in CDMO Sterile Injectables, CRDMO and Generics
Subscribe To Our Newsletter & Stay Updated